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Research Paper
Mice lacking Kcns1 in peripheral neurons show
increased basal and neuropathic pain sensitivity
Christoforos Tsantoulasa,*, Franziska Denka, Massimo Signoreb, Mohammed A. Nassarc, Kensuke Futaid,
Stephen B. McMahona
Abstract
Voltage-gated potassium (Kv) channels are increasingly recognised as key regulators of nociceptive excitability. Kcns1 is one of the
first potassium channels to be associated with neuronal hyperexcitability and mechanical sensitivity in the rat, as well as pain
intensity and risk of developing chronic pain in humans. Here, we show that in mice, Kcns1 is predominantly expressed in the cell
body and axons of myelinated sensory neurons positive for neurofilament-200, including Ad-fiber nociceptors and low-threshold Ab
mechanoreceptors. In the spinal cord, Kcns1 was detected in laminae III to V of the dorsal horn where most sensory A fibers
terminate, as well as largemotoneurons of the ventral horn. To investigate Kcns1 function specifically in the periphery, we generated
transgenic mice in which the gene is deleted in all sensory neurons but retained in the central nervous system. Kcns1 ablation
resulted in a modest increase in basal mechanical pain, with no change in thermal pain processing. After neuropathic injury, Kcns1
KO mice exhibited exaggerated mechanical pain responses and hypersensitivity to both noxious and innocuous cold, consistent
with increased A-fiber activity. Interestingly, Kcns1 deletion also improved locomotor performance in the rotarod test, indicative of
augmented proprioceptive signalling. Our results suggest that restoring Kcns1 function in the periphery may be of some use in
ameliorating mechanical and cold pain in chronic states.
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1. Introduction
Neuropathic pain remains suboptimally treated, with less than
half of patients achieving satisfactory pain relief.10 Consequently,
determining the molecular constituents of pain sensitivity, and in
particular genes influencing susceptibility to chronic pain,
remains an important endeavour of pain research.4,44,45,49
Voltage-gated potassium (Kv) channels have attracted signif-
icant interest as regulators of pain due to their fundamental role in
shaping nociceptive signalling. Kv activity in the dorsal root
ganglion (DRG) limits neuronal excitability and is characteristically
reduced in a range of pain syndromes, from traumatic and
metabolic neuropathies to autoimmune disorders.43 For
instance, members of the Kcna (Kv1) family set spike threshold
and firing frequency in the DRG, and Kv1 activity is attenuated in
rodents subjected to nerve injury and humans with idiopathic
pain.1,15,51 Kv function can also be altered by inflammation; thus,
“de-sensitisation” by inflammatory mediators reduces Kcnq2/3
(Kv7.2/Kv7.3) background (BG) conductance and promotes
DRG hyperexcitability.27
KCNS1, encoding the Kv9.1 subunit, is the first Kv gene
associated with chronic pain development in humans. Thus,
genetic analysis has linked KCNS1 polymorphisms to basal pain
sensitivity as well as propensity to develop phantom limb pain,
back pain, and HIV-associated pain.7,16,25 Kcns1 is abundantly
expressed in the DRG, spinal cord, and brain, but excluded from
nonneuronal tissues such as muscle, heart, lung, kidney, and
liver.36 In sensory nerves of rats, Kcns1mRNA is dramatically and
rapidly downregulated by nerve injury, with a time course that
matches the development of pain phenotypes.46 Recapitulating
the Kcns1 loss-of-function triggers neuronal hyperexcitability in
myelinated sensory neurons and induces mechanical sensitivity
in naive rats, suggesting that physiological Kcns1 activity is pain
protective.46 Interestingly, Kcns1 conduction is reliant on hetero-
merisationwithmembers of the Kcnb (Kv2) superfamily36; studies
in heterologous expression systems and simulations indicate that
although nonconducting on their own, the association of Kcns
with Kcnb members can stabilise the resultant currents and
promote closed-state inactivation that attenuates excitabil-
ity.23,34,37 Recent data using ex vivo recordings also support
the notion that Kcnb/Kcns1 signalling in sensory neurons is
indeed compromised by nerve injury.47
Further dissecting the role of Kcns1 is hampered by the lack of
pharmacological tools to specifically target this member within
the highly conserved Kv family. We have previously used
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intrathecal siRNAs to overcome this limitation; however, the
robust expression of Kcns1 in the nervous system made it
impossible to distinguish between peripheral and central effects
of the knock-down. To more thoroughly address this, we
generated Advillin-driven inducible transgenic mice in which
Kcns1 is selectively inactivated in DRG neurons. We phenotyp-
ically characterised these mice to assess the effect of peripheral
Kcns1 inhibition on a range of acute and neuropathic pain
modalities as well as locomotor behaviour.
2. Materials and methods
2.1. Animals
PCR was used to clone the mouse Kcns1 gene into a plasmid
containing loxP sites and a neomycin selection cassette flanked
by 2 frt sites. The resulting construct contained the entire
sequence of Kcns1, including flanking regions (2.3 kb upstream
of exon 1 and 0.95 kb downstream of the last exon 4). The coding
region of Kcns1 is restricted to exon 3, which was inserted
between the 2 loxP sites. The final targeting vector was
sequenced, linearised using a NotI digest, and electroporated
into 129 mouse embryonic stem (ES) cells. Positive clones were
identified by Southern blotting and PCR and used to generate live
mice. The ES cell manipulations and blastocyst injections were
performed by the Transgenic Services of the Institute of Child
Health at University College London. After breeding out the
neomycin resistance gene from founders using Flp recombinase
mice, the mouse line was crossed with AdvCreERT2 BAC
transgenics.26 The animals aremaintained as homozygous floxed
for kcns1 and hemizygous for Cre on a mixed 129SvEv and
C57BL/6 J BG.
Kcns1 deletion was induced by intraperitoneal injection of 75
mg/kg tamoxifen (Sigma, H7904) at a volume of 10 mL/kg body
weight, for 5 consecutive days. Tamoxifen was initially dissolved
in ethanol at a concentration of 100 mg/mL, and subsequently
diluted in autoclaved sunflower oil to achieve a stock solution of
10 mg/mL according to manufacturer’s instructions. A minimum
of 10 days was allowed after tamoxifen treatment, before
biochemical or behavioural assessment of the knock-out.
Micewere housed in groups of 5with standard rodent food and
water ad libitum, on a 12-hour light/dark cycle and allowed to
acclimatize to their environment for at least 1 week before study.
All procedures were compliant with the Home Office (United
Kingdom) regulations and Animals (Scientific Procedures) Act
1986, as well as guidelines established by King’s College
London, the Committee for Research and Ethical Issues of IASP.
2.2. Behavioural testing
Pain phenotypes were characterized using 8- to 12-week-old
mice. All behavioural testing was conducted during the day in
a quiet temperature-controlled room by an experimenter blinded
to mouse genotype. Acute phenotypes were assessed using
either male or female mice, whereas neuropathic pain was
assessed using male mice only, as indicated in the relevant
Results sections.
2.3. Mechanical pain
Mechanical sensitivity was assessed with the automatic von Frey
method using a dynamic plantar aesthesiometer (Ugo Basile).
Briefly, animals were placed in a ventilated Plexiglass cage on an
elevated wire mesh grid and allowed to acclimatize. Once
exploratory behaviour had ceased, an actuator filament
(0.5 mm diameter) under computer control delivered a 10-
second ramp of increasing force (0-5 g) to the plantar surface of
the hind paw until the animal withdrew the paw. Paw withdrawal
thresholds were averaged over at least 5 measurements with 5-
minute intervals between assays.
2.4. Noxious heat pain
Thermal sensitivity was evaluated with the Hargreaves method.
Mice were placed in a ventilated Plexiglass cage on an elevated
glass floor and allowed to acclimatize. A calibrated radiant light
source (Ugo Basile) delivered a constant thermal stimulus (190
mW/cm2) to the plantar hind paw, and the latency until withdrawal
was recorded. Withdrawal thresholds were averaged from at
least 5 consecutive tests, with a minimum of 5 minutes in
between measurements. A cutoff of 25 seconds was imposed to
prevent tissue damage.
2.5. Cold pain
Paw sensitivity to noxious cold was measured by placing mice on
a cold plate (Harvard Apparatus) set at 0˚C and counting the
number of paw lifts within a 2-minute period. To determine
sensitivity to a range of cold temperatures (both innocuous and
noxious) after nerve injury, mice were subjected to a 2˚C/minute
cooling ramp from 20˚C to 0˚C, as previously described.50 Paw
lifts of the ipsilateral side only and the temperature at which they
occurred were recorded and grouped into 2˚C bins for analysis.
Animals were removed from the plate 2 minutes after the
temperature reached 0˚C to prevent tissue injury.
2.6. Rotarod
Mice were placed on a moving rotarod (Ugo Basile) programmed
to accelerate from 4 to 40 rpm, over 120 seconds. After a 3-day
training period, the time the mice managed to remain on the
rotarod was averaged over 3 consecutive trials. Falls due to poor
placing by the experimenter (typically before 5 seconds had
elapsed on the rotarod) were excluded, and the trial repeated.
Mechanical, noxious heat pain, and cold pain thresholds were
measured sequentially on the same day, with at least a 2-hour
interval in between tests to avoid sensitization of the nociceptive
system,whereas locomotor behaviorwasassessedonaseparate
day.
2.7. Neuropathic pain model
Animals were anesthetized with isoflurane (Abbott Animal Health,
United Kingdom), and the left hind pawwas shaved and sterilized.
The sciatic nerve was carefully exposed and isolated from
neighboring connective tissue through a small incision midway of
the left thigh. A 5.0 vicryl suture (Ethicon) was inserted into the
nerve distal to the posterior biceps’ semitendinosus branch and
ligated so that approximately one-third to one-half of the nerve
was held tightly. Pain thresholds were assessed at uninduced
baseline, after tamoxifen treatment, and days 7, 10, 14, and 21
after injury.
2.8. Antibodies
To generate Kcns1 antibody, the C-terminal end region of mouse
Kcns1 (aa 469-497, NP_032461.2) was PCR amplified and
subcloned into pGEX-4T vector (glutathione S-transferase fusion
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protein, Amersham Pharmacia Biotech). Glutathione S-
transferase fusion proteins were purified using glutathione-
Sepharose 4B resin (Amersham Pharmacia Biotech) and used
to immunize rabbit. Kcns1 antibody was affinity purified using
glutathione S-transferase fusion protein. Primary antibodies and
their dilutions used in this study were: rabbit anti-Kcns1 (1:2000),
mouse anti-NeuN (1:1000, Abcam #ab104224), chicken anti-
b3tubulin (1:1000, Abcam #ab41489), chicken anti-peripherin (1:
500, Abcam #ab39374), goat anti-CGRP (1:1000, Abcam
#ab36001), chicken anti-NF200 (1:1000, Merck Millipore
AB5539), mouse anti-Nav1.8 (1:1000, Neuromab N134/12), goat
anti-CSF1 (1:1000, R&D Systems #AF416), and rabbit anti-ATF3
(1:500, Santa Cruz Biotechnology #sc-188). Secondary anti-
bodies used were donkey anti-mouse IgG-conjugated Alexa
Fluor 488 or 594, goat anti-chicken IgG-conjugated Alexa Fluor
594, donkey anti-rabbit IgG-conjugated Alexa Fluor 488 or 594,
and donkey anti-goat–conjugated Alexa Fluor 594 (all 1:1000,
Invitrogen). IB4 binding was visualized using biotin-conjugated
IB4 (1:200, Sigma L2140) and Avidin-FITC (1:500, Sigma).
2.9. Immunohistochemistry
Mice were culled through cervical dislocation; DRG and sciatic
nerve were removed and fixed in 4% paraformaldehyde in 0.1 M
phosphate buffer (pH 7.4) for either 20 minutes (DRG) or 2 hours
(nerve) at 4˚C. The spinal cord was removed after transcardial
perfusionwith 4%paraformaldehyde and fixed for 4 hours. Tissue
was equilibrated in 20% sucrose in phosphate-buffered saline
(PBS) at 4˚C for 24 hours (DRG) or 72 hours (spinal cord and
nerve), embedded in optimum cutting temperature (O.C.T., VWR
International) compound and rapidly frozen on liquid N2. Tissue
sections were cut at the required thickness (DRG, 10 mm; spinal
cord/nerve, 20 mm) on a cryostat and thaw mounted onto
Superfrost Plus glass slides (VWR). Before antibody staining,
nonspecific immunoreactivity (IR) was blocked by 1-hour in-
cubation in PBS supplemented with 0.3% Triton X-100 (Sigma),
4% donkey serum (Jackson ImmunoResearch Labs), and 0.5%
skimmed milk (Tesco).
Slides were washed in PBS and incubated overnight at 4˚C
with the primary antibody in staining buffer solution (PBS
supplemented with 0.3% Triton X-100). The following day, slides
were washed and incubated for 2 hours with staining buffer
containing the appropriate secondary antibodies. After a final
wash, slides were mounted with FluorSave mounting medium
(Calbiochem).
2.10. Image analysis
Antibody staining was visualized on a fluorescence microscope
(Zeiss), and images were acquired using a digital camera running
Axiovision software. For quantification of Kcns1 immunoreactivity
(IR), staining was performed at the same time across all samples
to minimize experimental variability, and the same exposure
settings were used for image acquisition. Analysis of Kcns1 signal
was performed with ImageJ software (http://rsbweb.nih.gov/ij/).
For each image, 3 background (BG) measurements were taken,
and the mean intensity of BG as well as standard error (SEM) was
calculated; a cell was only considered positive when the intensity
of its IR was higher than 2xBG1 2xSEM. These objective criteria
correlated well with subjective criteria of positively labelled cells.
Measurements were conducted using images taken with a 253
objective, only on cells that had a clearly visible nucleus. Between
100 and 200 DRG neurons and 50 to 100 motoneurons per
animal were quantified.
2.11. Western blot
Full-length kcns1 cDNA was PCR amplified from mRNA isolated
from hippocampal primary neurons and cloned in the pCAG-
EGFP vector. The shRNA vector targeting kcns1 was purchased
from Dharmacon (V2LMM_218480). For immunoblotting, HEK
293T cells were transfected with Kcns1 with or without Kcns1
shRNA using lipofectamine 2000 (Invitrogen). Protein lysates
were harvested 3 days after transfection, and immunoblotting
was performed using custom-made rabbit anti-kcns1 antibody
(1 mg/mL) followed by HRP-conjugated anti-rabbit IgG antibody
(GE Healthcare, Little Chalfont, United Kingdom, 1:2000) and
Western Lightning Plus-ECL (Perkin Elmer, Waltham, MA).
2.12. Quantitative real-time PCR
Mice were killed with an overdose of pentobarbital, perfused with 10
mL PBS and their lumbar DRG dissected and snap frozen in liquid
nitrogen. RNA was extracted using a hybrid method of phenol
extraction (TRIzol; Invitrogen Carlsbad, CA) and column purification
(RNeasy Microkit; Qiagen, Hilden, Germany), including DNase
treatment to prevent genomic contamination. After purification, the
RNA was eluted with RNase-free water, and its concentration and
purity estimated with a NanoDrop ND-100 spectrophotometer
(Thermo Fisher Scientific). First strand cDNA was reverse transcribed
using Superscript II Reverse Transcriptase, reaction buffer, DTT (all
from Invitrogen), random primers, and dNTP mix (Promega),
according to the manufacturer’s guidelines. Three different sets
of exon-spanning primers were used to quantify Kcns1
levels in DRG using standard qRT-PCR: ex1-2: 59F-
tggagaccaatacagttgtaggtaa, 59R-tggacaagcttggatttggga; ex2-3:
59F-gagccaccgtggacatttgg, 59R-acgacagtgtgcctcccttg; ex3-4: 59F-
tagtgcaagtgttccgcctc, 59R-cctcacggtagctgtgcttg. All primers were
assessed for their efficiency and specificity, and the ddCT method
was used with ywhaz (59F-agtcgtacaaagacagcacgctaa, 59R-
aggcagacaaaggttggaagg) and gapdh (59f-aggtcggtgtgaacggatttg,
59r-tgtagaccatgtagttgaggtca) as housekeepers.
2.13. Statistical analysis
All data are presented asmean6SEM, and group sizes are noted in
each figure legend. All replicates refer to biological replicates.
Statistical significance was determined using GraphPad Prism
version 6.0 (La Jolla) using the unpaired, equal variance, 2-tailed
Student t test, 1-way or 2-way analysis of variance, and Tukey post
hoc, as indicated in thecorresponding figure legends.All significance
tests were justified as appropriate given the study design and nature
of comparisons. Significance levels are indicated by: *P, 0.05; **P
, 0.01; and ***P, 0.001. A P, 0.05 was considered significant.
3. Results
3.1. Kcns1 expression in sensory neurons
We first investigated Kcns1 expression in the mouse DRG using
Kcns1 immunohistochemistry. Kcns1 protein was detected in
approximately 40% of all neurons, identified by their IR to b3tubulin
(Suppl. Fig. 1A, available online at http://links.lww.com/PAIN/
A575). Themajority of Kcns1 signal was localised inmedium–large
diameter neurons that also stained for neurofilament-200 (NF200).
Thus, cell size distribution analysis revealed that 40.8% of medium
and 69.2% of large diameter neurons expressed Kcns1. By
contrast, very little expression was found in small nociceptive
neurons, distinguished by peripherin labelling (Suppl. Fig. 1B,
available online at http://links.lww.com/PAIN/A575). Accordingly,
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Kcns1 expression showed very limited overlap with that of
calcitonin gene-related peptide (CGRP) and isolectin B4 (IB4) in
peptidergic and nonpeptidergic nociceptors, respectively, with the
notable exception of some larger neurons positive for CGRP. This
expression profile suggests that in themouse, Kcns1 is enriched in
myelinated A fibers, including nociceptive (ie, Ad and a minority of
Ab) and nonnociceptive (ie, Ab low-threshold mechanoreceptors)
afferents, in agreement with our previous report on Kcns1
expression in the rat.
In the spinal cord, Kcns1 IR was more pronounced in neurons
of laminae III to V of the dorsal horn as well as larger neurons in
deeper laminae VI and VII. By contrast, very little Kcns1 staining
was detected in laminae I to II, where small nociceptors terminate.
In addition, Kcns1 signal was particularly prominent in largemotor
neurons of the ventral horn (Fig. 1). This expression pattern is
consistent with the selective expression of Kcns1 in A fibers, most
of which project to laminae III to V, with the sporadic staining in
lamina I most likely corresponding to Ad-fiber terminals.
We next examined Kcns1 expression in the peripheral nerve. In
line with expression of this protein in medium–large DRG
neurons, Kcns1 IR could be seen along many NF200-positive,
but also some of the larger CGRP-positive fibers of the sciatic
nerve (white arrows in Fig. 2). Some of the Kcns1 signal was
retained in tissue from KO mice and did not colocalise with
b3tubulin (Suppl. Fig. 2, available online at http://links.lww.com/
PAIN/A575), suggesting nonneuronal IR. Omitting the primary
antibody gave a similar pattern (Suppl. Fig. 3, available online at
http://links.lww.com/PAIN/A575), suggesting that this residual
signal is due to tissue autofluorescence and/or nonspecific IR of
the secondary antibody. In agreement with this, RNA sequencing
of Schwann cells isolated from the rat sciatic nerve indicates that
Kcns1 transcript is absent in both naive and injured (nerve crush)
conditions (Ref. 3 and personal communication with Brosius
Lutz).
3.2. Generation of Kcns1 transgenic mice
Having characterized its expression in the DRG, we sought to
genetically silence Kcns1, specifically in the peripheral nervous
system. To this end, we used tamoxifen-induced Cre recombi-
nation under the control of the Advillin promoter to delete the
Kcns1 gene in all sensory neurons. Floxed Kcns1 knock-in mice
were generated by blastocyst injection (Fig. 3A), and crossed
with existing AdvCreERT2 BAC transgenic mice26 to allow for
spatially and temporally controlled deletion of Kcns1.
Quantification of Kcns1 mRNA by quantitative real-time PCR
after tamoxifen treatment confirmed a large reduction in mRNA
levels of Kcns1 cKO mice compared with floxed littermates
(Kcns1 f/f) (Fig. 3B). We used 3 pairs of exon-spanning primers
targeting all exons of the gene, including the floxed coding exon 3.
As expected by the design of the transgenic line, amplification
with primers binding within exon 3 indicated large mRNA
Figure 1. Kcns1 expression in the mouse spinal cord. In the lumbar spinal cord, Kcns1 signal was detected in deeper laminae of the dorsal horn, where A fibers
terminate. Thus, very little Kcns1 staining was observed in laminae I to II, but many immunoreactive neurons could be seen in laminae III to V (arrows in magnified
inset a) and deeper laminae V to VI (inset b). Kcns1 labelling was also evident in large motoneurons of the ventral horn (inset c). Kcns1 appeared restricted to
neuronal cells, as indicated by colocalisation with NeuN and the absence of staining in the white matter. Observations from n 5 4 mice. Scale bars 5 100 mm.
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reductions in cKO mice (primers 2-3 and 3-4, reductions of 97%
and 89% compared with Kcns1 f/f, P , 0.001 and P 5 0.002,
respectively). Amplifying the two 39 untranslated regions pre-
ceding the targeted exon (primers 1-2) also demonstrated a 54%
reduction, presumably due to degradation of incompletely
formed Kcns1 mRNAs (P 5 0.007).
Next, we confirmed that thismRNA reduction resulted in loss of
the translated protein, by examining Kcns1 IR in DRG neurons
after tamoxifen induction (Fig. 3C). In the control littermates,
Kcns1 IR was observed in medium–large neurons, the majority of
which are negative for the nociceptive neuron marker Nav1.8. In
cKO mice, however, Kcns1 staining was virtually absent from
both small and medium–large neurons, confirming deletion at the
protein level. To confirm that gene deletion is restricted to
peripheral neurons, we also examined Kcns1 expression in large
motoneurons of the spinal cord in tamoxifen-induced control and
KO mice (Suppl. Fig. 4, available online at http://links.lww.com/
PAIN/A575). Kcns1 IR was high in both groups, expressed in
more than 90% of motoneurons with no statistical difference
between genotypes (93.56 1.1% vs 91.96 0.7% for floxed and
cKO, respectively, P 5 0.253). Quantification of denaturated
protein levels using western blot was not feasible as the antibody
produced nonspecific results in this application (Suppl. Fig. 5,
available online at http://links.lww.com/PAIN/A575).
3.3. Acute pain processing in Kcns1 cKO mice
To characterize the effect of peripheral Kcns1 deletion on acute
pain, we compared mechanical thresholds of male Kcns1 cKO
mice and Kcns1 f/f littermates (Fig. 4A, left graph), using the
automatic von Frey method. Before tamoxifen induction (“unin-
duced”), both genotypes showed similar responses to stimulation
(4.2 6 0.1 vs 4.1 6 0.2 g, respectively; P . 0.05). After gene
induction, however (10 days post-tamoxifen), there was an
approximately 20% reduction of mechanical thresholds in the
cKO group (down to 3.4 6 0.2 g, P , 0.01 vs uninduced cKO
baseline). By contrast, no significant reduction was found in the
f/f littermates after tamoxifen induction (P. 0.05 vs uninduced
f/f baseline). This result suggests an effect of gene knock-out,
although the difference between genotypes after tamoxifen did
not reach significance (P . 0.05; tamoxifen f/f vs tamoxifen
cKO). A more pronounced effect was observed in female mice
(Fig. 4A, right graph); gene deletion induced a 20% decrease in
cKO thresholds of female mice (from 4.46 0.1 to 3.46 0.2 g; P
, 0.001), which was also 15% lower than the corresponding
values in the f/f group after tamoxifen (4.0 6 0.2; P , 0.05).
Pooling male and female data together also resulted in
a significant reduction of mechanical thresholds when com-
paring genotypes after tamoxifen (Suppl. Fig. 6, available online
at http://links.lww.com/PAIN/A575; 3.8 6 0.2 vs 3.4 6 0.2; P
, 0.05), reinforcing the idea that Kcns1 deletion triggers
mechanical hypersensitivity. Pooling the data also revealed
a statistically significant difference between uninduced and
treated conditions for each genotype (P , 0.001 for Cre and P
, 0.05 for floxed), likely indicating a toxicity-induced effect by
tamoxifen.
When assessing noxious heat thresholds after tamoxifen using
the Hargreaves method, we found no difference between
genotypes (Kcns1 f/f, 10.4 6 0.7 seconds vs Kcns1 cKO, 10.8
6 0.4 seconds; P. 0.05), suggesting that Kcns1 is not involved
in determining basal heat pain (Fig. 4B). In addition, tamoxifen
induction did not affect responses to noxious cold (Fig. 4C); thus,
Kcns1 f/f and Kcns1 cKO mice exhibited similar numbers of paw
lifts on average when placed on a cold plate at 0˚C (5.7 6 1.3 vs
4.5 6 1.3 lifts, respectively; P 5 0.53). Together, these data
indicate that Kcns1 deletion causes a modest increase in
mechanical pain sensitivity but does not affect basal thermal
processing.
Figure 2. Kcns1 expression in the peripheral nerve. Kcns1 was detected along myelinated nerve fibers of the sciatic nerve, indicated by colocalisation with
b3tubulin (white arrows). The Kcns1-expressing fibers were also found to express NF200 andCGRP, in agreement with the documented Kcns1 expression profile
in the DRG. Some of the Kcns1-IR appeared to be nonneuronal (yellow arrows). Observations from n 5 4 mice. Scale bars 5 40 mm. CGRP, calcitonin gene-
related peptide; DRG, dorsal root ganglion; IR, immunoreactivity.
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Interestingly, when investigating locomotor behavior (Fig. 4D),
we found that Kcns1 cKO mice performed better on the rotarod
test compared with floxed littermates (58.7 6 3.6 vs 48.1 6 2.9
seconds, respectively; P5 0.03). This result suggests that Kcns1
deletion in the DRG may enhance excitability of proprioceptive
neurons, leading to increased locomotor activity.
3.4. Neuropathic pain responses of Kcns1 cKO mice
We next examined whether Kcns1 deletion in sensory neurons
impacts neuropathic pain induced by nerve injury. Tamoxifen-
treated Kcns1 f/f and cKO mice (“post-TAM”) were subjected to
a partial sciatic nerve ligation (Seltzer model), and pain thresholds
were monitored thereafter. Nerve injury reduced mechanical pain
thresholds in the Kcns1 f/f group compared with preinjury values,
commencing on day 7 and persisting throughout the post-
operative period studied (P, 0.01 vs post-TAM) (Fig. 5A). Nerve
damage also reduced mechanical pain thresholds in cKO mice
during the same period (P, 0.05 vs post-TAM) and from day 10
onwards, thresholds were significantly lower than the respective
ones in the floxed group (P, 0.05 vs Kcns1 f/f). More specifically,
thresholds of cKO mice were 27% lower than those of f/f mice at
10 days (2.26 0.1 vs 3.96 0.2 g; P, 0.01), and the magnitude
of this difference was similar at 21 days (2.06 0.1 vs 2.76 0.2 g;
26% difference; P , 0.01). These results demonstrate that after
neuropathic injury, cKO mice develop greater mechanical
hypersensitivity compared with control littermates.
When examining responses to a radiant heat source, we found
that both groups developed similar levels of heat pain sensitivity
after nerve damage (Fig. 5B). Thus, thresholds to heat stimulation
dropped by approximately 30% after injury (f/f, 10.46 0.7 [post-
tam] to 6.96 0.7 [7 days] and 6.96 0.6 seconds [10 days]; cKO,
10.8 6 0.7 [post-tam] to 7.3 6 0.6 [7 days] and 8.2 6 0.9
seconds [10 days]), with no significant difference between
genotypes at any time point (P . 0.05).
We finally investigated hownerve injury impacts responses to cold
stimuli in these mice (Fig. 5C). For this, the mice were subjected to
a temperature ramp (20-0˚C), and responses on the ipsilateral side
(day 10 after surgery) were assessed. Quantifying the average
number of responses during thewhole temperature ramp (left panel)
revealed that Kcns1 cKO mice exhibited more paw lifts on average
compared with nerve-injured f/f mice (16.16 3.9 vs 5.56 1.7 paw
lifts, respectively; P 5 0.02). Examining the distribution of the
responses during the temperature ramp (right panel) confirmed
significantly augmentedcold hypersensitivity in cKOmice (P50.012
comparing distributions), with the biggest effect observed around
10˚C (P , 0.01) and 0˚C (P , 0.001). These data indicate that
peripheral Kcns1 deletion increases sensitivity to both innocuous
and noxious cold temperatures after nerve injury.
3.5. Neurochemical changes after nerve injury
Previous work in rats has shown that traumatic nerve injury
induces a dramatic Kcns1 downregulation at the mRNA level.46
To extend these findings and gain more insight into the observed
phenotypes in mice, we characterized Kcns1 expression in DRG
of f/f and cKO mice at the behavioural end point (21 days post-
Seltzer) (Fig. 6A). Strong Kcns1 staining was evident in the
Figure 3.Generation of Adv-CRE inducible Kcns1 conditional KO (cKO) mice. (A) Floxed Kcns1 knock-in mice were generated using homologous recombination
in ES cells and subsequent blastocyst injections. (A) Schematic of the targeting construct is displayed here. Successful clones were identified using Southern
blotting (middle,1: mutant clone) and PCR (right, 1: original targeting plasmid and 2: successful ES cell clone). The neomycin cassette was removed using an flp
enzyme, and the resulting Kcns1mice were crossed with the AdvCreERT2 line to generate an inducible knock-out of the Kcns1 gene in sensory and sympathetic
neurons. (B) After induction of gene knock-out through tamoxifen treatment, DRG from cKOmice and floxed controls were analysed for Kcns1 mRNA expression
by qPCR. Using primers amplifying within the deleted region of exon 3 (primer pairs 2-3 and 3-4), we found 97% and 89% reductions of Kcns1mRNA in cKOmice
compared with floxed controls. Using primers that bind before the targeted exon (exons 1-2), we also observed a 54% reduction in Kcns1 transcripts, most likely
indicating degradation of incompletely formed mRNAs (**P,0.01, ***P,0.001; n5 3/group, the Student t test). (C) Kcns1 transcript reduction in cKO mice was
also reflected at the protein level, as revealed by Kcns1 immunoreactivity in the DRG after tamoxifen treatment. As expected, Kcns1 protein was detected in
medium–large, predominantly Nav1.8-negative neurons of floxed controls but was virtually absent from cKOmice. Observations from n5 3mice/group. Scale bar
5 40 mm. DRG, dorsal root ganglion; ES, embryonic stem; qPCR, quantitative real-time PCR.
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contralateral (uninjured) side of the f/f mice; however, Kcns1
signal was substantially attenuated by nerve damage on the
ipsilateral side. Quantification of Kcns1 IR showed a significant
decrease in the percentage of Kcns1-positive neurons from 46.9
6 4.0% to 25.6 6 5.0% (P , 0.01) on the injured DRG (Fig. 6B,
left). Notably, residual Kcns1 signal remained after nerve damage,
most likely corresponding to neurons that were unaffected by the
partial nerve injury (two-thirds to a half of all DRG neurons in this
model). Indeed, neurons positive for the nerve injury marker
colony-stimulating factor 1 (CSF1)13 showed no IR for Kcns1,
whereas neurons that retained Kcns1 labelling were negative for
this marker (Fig. 6C).
Figure 4. Kcns1 deletion from sensory neurons affects basal pain processing. (A) Sensitivity to mechanical stimulation of the hind paw in conditional KO (Kcns1 cKO) and
littermate control (Kcns1 f/f) male (left) and female (right) mice. Before induction of gene deletion with tamoxifen (“uninduced”), there is no difference in responses between
genotypes (P. 0.05, the Student t test). However, 10 days after induction, there is a;20%decrease in pain thresholds in cKOmice compared with preinduced baseline
(*P,0.05, **P,0.01, ***P,0.001; n511malemice andn512 femalemice/group; 2-way repeated-measuresANOVAwith Tukey) (see alsoSuppl. Fig. 6, available online
at http://links.lww.com/PAIN/A575). (B) Responses to noxious heatwere not affectedbyKcns1deletion, as assessedwith theHargreavesmethod10dayspost-tamoxifen
(P.0.05; n511malemice/group; 2-way repeated-measuresANOVA). (C) Kcns1 cKOmice and floxed littermates exhibited similar responses to noxious cold stimulation
when placed on a 0˚C cold plate (P . 0.05; n 5 12 female mice/group; the Student t test). (D) Kcns1 deletion from sensory neurons resulted in enhanced locomotor
performance in the rotarod test (*P,0.05; n5 12 female mice/group; the Student t test). ANOVA, analysis of variance.
Figure 5.Peripheral Kcns1 deletion triggers exaggerated pain phenotypes after nerve injury. (A) After tamoxifen treatment, themice were subjected to partial nerve
ligation and pain phenotypesmonitored thereafter. Nerve injury resulted in pain hypersensitivity in both genotypes lasting for 3weeks following the insult (#P, 0.05
vs post-TAM). In addition, pain thresholds in the cKO group were 27% lower compared with the floxed group at day 10 (**P , 0.01) and remained significantly
lower thereafter (n5 11 male mice/group; 2-way repeated-measures ANOVA with Tukey). BL, pretamoxifen baseline; post-TAM, post-tamoxifen; dpi, days post
injury. (B) Nerve damage decreased heat pain thresholds (###P, 0.001 vs post-TAM), but there was no difference between genotypes (n5 11male mice/group;
2-way repeated-measures ANOVA). BL, pretamoxifen baseline; post-TAM, post-tamoxifen; dpi, days post injury. (C) Kcns1 deletion also affected behavioural
responses to innocuous and noxious cold temperatures at 10 days after injury, manifested as increased paw lifting during a cold temperature ramp from 20 to 0˚C.
Left, cKO mice showed more paw lifts on average (P, 0.05, n5 11 male mice/group; the Student t test) during the ramp. Right, distribution of responses (P,
0.05; the Kolmogorov–Smirnov test) demonstrating cold hypersensitivity of cKOmice, particularly around temperatures of 10˚C (P, 0.01) and 0˚C (P, 0.001, n5
11/group; 2-way repeated-measures ANOVA with Tukey). ANOVA, analysis of variance; cKO, conditional KO.
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Interestingly, when quantifying signal intensity (Fig. 6B, right),
there was no difference between ipsi and contra sides (31.26 4.0
vs 28.8 6 0.6 arbitrary units; P 5 0.59), suggesting that injured
neurons have completely lost Kcns1 protein at this time point,
whereas spared neurons retain baseline levels of expression.
Finally, as anticipated Kcns1 protein was virtually absent in both
ipsilateral and contralateral DRG neurons of cKO mice. This
expression profilematches the altered pain responses in cKO and
f/f mice after injury and further supports an inversely proportional
relationship between reduced Kv9.1 function and magnitude of
pain hypersensitivity.
4. Discussion
Kcns1 was first implicated in nociception by gene association
studies pinpointing protective haplotypes influencing acute pain
Figure 6. Kcns1 protein expression after nerve injury in cKO and control mice. (A) Kcns1 expression on the contralateral (uninjured) and ipsilateral (injured) DRG
from cKO and floxed littermate mice, 21 days after nerve damage. Kcns1 IR is largely attenuated by nerve injury in control mice; however, some Kcns1-positive
neurons are still visible (arrows, top row). By contrast, no signal could be observed in either DRG from cKOmice (bottom row). (B) Quantification of percentages of
Kcns1-positive neurons (**P, 0.01; n5 3/group; 1-way ANOVA with Tukey) and signal intensity (P. 0.05, n5 3/group; the Student t test). Scale bar5 40 mm.
(C) Downregulation of Kcns1 in injured DRG neurons. Top panels, a fraction of small and medium–large sensory neurons are labelled with the nerve injury marker
CSF1 at 21 days post-Seltzer. These injured neurons show no Kcns1 immunoreactivity (white arrows), which is however retained in CSF1-negative neurons
(yellow arrows). Bottom panels, CSF1-positive neurons (arrows) show strong nuclear immunoreactivity for the injury marker ATF3. Scale bars, 40 mm. ANOVA,
analysis of variance; cKO, conditional KO; DRG, dorsal root ganglion; IR, immunoreactivity.
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intensity and neuropathic pain incidence in humans.7,25 Further
work demonstrated that intrathecal delivery of Kcns1 siRNAs
augmented mechanical pain in rats46; however, a contribution of
Kcns1 knock-down in the central nervous system could not be
ruled out. Here, we conclusively demonstrate that targeted Kcns1
deletion in peripheral sensory neurons is sufficient to increase
basal mechanical sensitivity, independently of any central Kcns1
function. A second major finding is that peripheral Kcns1
inhibition predisposes towards neuropathic pain, evident by
increased mechanical sensitivity in nerve-injured KO mice. Third,
we show for the first time that Kcns1 activity is also linked to
augmented responses to cold temperatures after neuropathic
injury. Finally, we found that Kcns1 knock-out increases
locomotive ability, presumably through an increase in pro-
prioceptor excitability.
Kcns1 expression in the mouse was similar to that previously
reported in the rat.46 Kcns1 protein was predominantly detected
in medium–large myelinated neurons and was almost absent
from small nociceptive neurons. Kcns1 could also be detected in
some medium–large neurons immunoreactive for Nav1.8, in
agreement with previous estimates that as many as 40% of
NF200-positive neurons also express Nav1.8.
38 Thesemost likely
represent Ad and Ab nociceptors containing pain-signalling
neuropeptides such as CGRP and substance P; we indeed
observed Kcns1 colocalisation with CGRP in many of these
neurons. Away from the cell body, Kcns1 was found along
primary afferents extending to the periphery. Many Kv channels
occupy juxtaparanodal regions in myelinated neurons, including
the Kcns1-interacting subunits Kcnb1 and Kcnb2,24,44 and
recent data show that Kv complement and organisation in nodes
of Ranvier can dynamically change after nerve injury to regulate
excitability.5 It would therefore be informative to examine nodal
assembly of Kcns1 and whether it is affected by nerve lesions in
future studies. The high-activation threshold and slow kinetics of
Kcnb channels suggest that tetrameric channels with Kcns1
subunits may be progressively recruited during sustained
nociceptive stimulation, in contrast to other Kv channels in nerve
terminals that can counteract depolarisation rapidly, such as A-
type channels.35 The diverse complement and topology of Kv
channels with distinct biophysical propertiesmay provide sensory
neurons with a powerful means to fine-tune nociceptive
excitability.
Deletion of Kcns1 from sensory neurons resulted in a modest
increase in acute pain, ie, an 8% reduction in mechanical
thresholds. This mechanical hypersensitivity is presumably
mediated by increased signalling in high-threshold mechano-
sensitive A fibers (primarily Ad but could also include Ab
nociceptors), and such A-fiber hyperexcitability has indeed been
shown after Kcns1 deletion.46 This enhanced nociceptive
signalling aligns well with the finding that human KCNS1
polymorphisms are associated with pain sensitivity in healthy
volunteers,7 as well as pain intensity in patients with breast
cancer.25 In addition, we show for the first time that peripheral
Kcns1 knock-out leads to augmented neuropathic pain pheno-
types after nerve injury; this is in agreement with a well-described
link between severity of acute pain and propensity for the
development of chronic pain in humans, for instance, in the
context of persistent postoperative pain.22
One area of debate is whether susceptibility to chronic pain is
simply the manifestation of such acute pain hypersensitivity in
a chronic setting. Our data suggest that there is limited overlap
between the two; nerve damage triggered a 27% reduction in
mechanical pain thresholds; however, less than a third of this
change could be justified by the effect of Kcns1 deletion on acute
pain (;8% reduction). The mechanisms governing the remaining
difference are not clear, but a likely explanation is that under
chronic pain conditions, Kcns1 works in synergy with injury-
induced plasticity, such as inhibition of other Kv channels and/or
sensitization of Nav and HCN channels.
44,45,49 According to one
hypothesis, hyperactivity in low-threshold Abmechanoreceptors
due to Kcns1 dysfunction can mediate mechanical allodynia in
neuropathic states due to central sensitisation maintained by C-
fiber input. It has been proposed that central sensitisation may
even be partly sustained by activity in Ab fibers that have
undergone injury-induced phenotypic switch in their neurochem-
ical complement.42 A role of A fibers in chronic pain is supported
by the fact that soon after neuropathic injury, the bulk of
maladaptive activity is manifested as spontaneous firing in these
fibers.29 Kcns1 may promote such activity, and we have indeed
shown that reduced Kcns1 function triggers spontaneous
firing.46
Tamoxifen treatment also appeared to have an algogenic effect
on mechanical thresholds. This result agrees with recent work
highlighting transient toxicity of tamoxifen 4 days after single
administration, resulting in cellular stress and induction of nerve
injury markers in DRG neurons, particularly proprioceptors.8
Although we accessed pain phenotypes 10 days post-treatment,
it is possible that some toxicity-induced effects were still present
because of the repeated administration regime required for
induction of gene KO.
Furthermore, our data expand the role of Kcns1 in nociception by
identifying an involvement in cold pain processing. Although Kcns1
deletion did not impact acute detection of noxious cold, we
documented a marked sensitivity to both innocuous and noxious
cold temperatures in neuropathic conditions. This effect ismost likely
mediated by Ad fibers, which can signal a range of cold temper-
atures,39 as illustrated by the complete suppression of cold
responses after Ad-fiber block.30 Interestingly, nerve injury increases
the proportion of cold-sensitive Ad fibers,18 and it has been
proposed that this may be related to removal of an excitability brake
normally provided by K1 channel conductance.12,31,32,48 Kcns1
loss-of-function could act as a similar disinhibition mechanism that
promotes conversion of cold-insensitive fibers into cold-sensitive.
Although cold sensitivity has also been described in largemyelinated
afferents (eg, slowly adapting mechanoreceptors such as Merkel
disks and Ruffini endings in the skin), these responses are much
smaller and therefore unlikely to make a major contribution to cold
sensing.17,19
Consistent with previous reports in the rat, Kcns1 deletion did
not affect responses to noxious heat.46 This is expected because
heat pain in glabrous skin is encoded by activity in TRPV1-
expressing small nociceptive fibers, and our histology indicates
that Kcns1 is largely absent from these.14 Although Ad fibers (type
II) in hairy skin can signal the “first” sharp pain in response to
noxious heat (a component which can be abolished by A block),
these afferents are not present in glabrous skin.33 Given the
existence of a subset of warm-sensitive afferents conducting
within the A-fiber range, it would be interesting to investigate
whether warm responses are modulated by Kcns1 deletion.41
Kcns1 knock-out also improved locomotor function. This is
attributed to a loss of Kcns1 function in proprioceptive A fibers
(which also express interacting partners Kcnb1 and Kcnb247)
because Kcns1 expression in spinal motoneurons was unaltered
by the Advillin-driven knock-out. One possible explanation is that
loss of Kcns1 promotes excitability in Aa fibers leading to
enhanced proprioceptive feedback to muscle spindles, Golgi
tendons, and joints and thus improved motor coordination. The
robust Kcns1 expression documented in spinal cord
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motoneurons may be indicative of a more generalised role in
motor function, especially because these neurons also express
Kcnb subunits.20 Interestingly, Kcns1 is also abundantly
expressed in the dorsal cochlear nucleus of the cerebellum, an
auditory structure that processes incoming proprioceptive
information.11,21
Our results suggest that restoring Kcns1 activity in the
periphery has therapeutic potential in chronic pain. Given the
involvement of K1 channels in the pathophysiology of divergent
pain syndromes, it would be informative to ascertain pain
phenotypes of Kcns1 KO mice in experimental paradigms
mimicking other pain states. For instance, the cold allodynia that
develops during cancer treatment with oxaliplatin is associated
with inhibition of K1 channels in A fibers, and intraplantar
administration of a K1 channel blocker can induce cold
sensitivity.9,40 Painful diabetic neuropathy has been associated
with a reduction in sustained delayed K1 currents in myelinated
DRG neurons,6 and Kcnb1 channels are chief determinants of
this conductance.2 As diabetes does not induce any transcrip-
tional change in Kcnb subunits,6 it is possible that altered
modulation by Kcns1 subunits underlies the observed electro-
physiological phenotype. Finally, it would be interesting to
investigate Kcns1 function in models of inflammatory pain,
particularly because accumulating data suggest that some Kv
channels can be directly modulated by inflammatory
mediators.27,28
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